Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Delcath Systems Inc (NQ: DCTH )

7.954 -0.136 (-1.68%)
Streaming Delayed Price Updated: 11:49 AM EDT, May 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Delcath Systems Inc

< Previous 1 2 3 Next >
Why Is Delcath Systems (DCTH) Stock Up 72% Today?
Delcath Systems (DCTH) stock is rocketing higher on Tuesday after getting an update from the FDA for its cancer treatment. 
Via InvestorPlace
Exposures Product Safety
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Pre-market stock movers are a hot topic with investors this morning and we're checking out the biggest ones worth watching on Tuesday! 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Earnings Scheduled For May 12, 2023
Companies Reporting Before The Bell • Honda Motor Co (NYSE:HMC) is expected to report earnings for its fourth quarter. 
Via Benzinga
Earnings Outlook For Delcath Systems
Via Benzinga
Looking Into Delcath Systems's Return On Capital Employed
Via Benzinga
Why Krispy Kreme Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Edible Garden AG Incorporated (NASDAQ: EDBL) shares jumped 58% to $1.88 after the company reported better-than-expected second-quarter financial results. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Delcath Systems Shares Are Jumping Today
Via Benzinga
Delcath Systems's Return On Capital Employed Overview
Via Benzinga
Delcath Systems Stock Jumps After Data Update From Eye Cancer Trials At ASCO Meeting
Via Benzinga
Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 59.6% to $0.2513. Crown Electrokinetics said it has entered into an agreement with a leading infrastructure solutions provider. 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Delcath Systems: Q2 Earnings Insights
  Delcath Systems (NASDAQ:DCTH) reported its Q2 earnings results on Monday, August 8, 2022 at 07:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Recap: Delcath Systems Q1 Earnings
Delcath Systems (NASDAQ:DCTH) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Outlook For Delcath Systems
Delcath Systems (NASDAQ:DCTH) is set to give its latest quarterly earnings report on Monday, 2022-08-08. Here's what investors need to know before the announcement. Analysts estimate that Delcath... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Hanger (NYSE:HNGR) stock moved upwards by 27.1% to $18.75 during Thursday's after-market session. The company's market cap stands at $731.7 million. 
Via Benzinga
79 Biggest Movers From Yesterday
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 154.7% to settle at $12.10 on Tuesday on continued strength after the FDA granted clearance for the company's pūrgo technology, classifying it... 
Via Benzinga
Mid-Afternoon Market Update: Dow Rises 100 Points; Kiromic BioPharma Shares Spike Higher
U.S. stocks turned higher toward the end of trading, with the Dow Jones gaining more than 100 points on Tuesday. 
Via Benzinga
Mid-Day Market Update: Nasdaq Turns Higher; REV Group Shares Plunge
U.S. stocks pared losses, with the Nasdaq Composite turning higher midway through trading on Tuesday. 
Via Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) gained 70% to $0.4900 after the company entered a sponsored research agreement under which in vivo preclinical data will be generated from Kiromic's Gamma... 
Via Benzinga
The Daily Biotech Pulse: Veru Seeks Emergency Use Nod For COVID-19 Therapy, Vincerx Cuts Workforce, Moderna Starts Dosing In Flu Vaccine Study
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Vaxxinity (NASDAQ:VAXX) stock moved upwards by 10.2% to $3.56 during Monday's after-market session. The company's market cap stands at $448.5 million. 
Via Benzinga
The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More
Biotech stocks reversed course along with the broader market and closed the week ending June 3 lower. The sector's lean run thus got extended. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Avalon Globocare (NASDAQ:AVCO) stock rose 14.8% to $0.54 during Tuesday's after-market session. The market value of their outstanding shares is at $47.8 million. 
Via Benzinga
Recap: Delcath Systems Q4 Earnings
Delcath Systems (NASDAQ:DCTH) reported its Q4 earnings results on Friday, March 25, 2022 at 07:30 AM. Here's what investors need to know about the announcement.... 
Via Benzinga
Earnings Scheduled For March 25, 2022
Companies Reporting Before The Bell DXP Enterprises, Inc. (NASDAQ: DXPE) is expected to report quarterly earnings at $0.14 per share on revenue of $285.00 million. BRP... 
Via Benzinga
Delcath Systems's Earnings Outlook
Delcath Systems (NASDAQ:DCTH) is set to give its latest quarterly earnings report on Friday, 2022-03-25. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
Delcath Systems Earnings Conference Call Is Coming Up, Here's What You Need To Know
Delcath Systems (NASDAQ:DCTH) will host a conference call at 08:30 AM ET on March 25, 2022, to discuss Q4 2021 earnings results. How to Attend Delcath Systems (DCTH)... 
Via Benzinga
Delcath's Chemosat Hepatic Delivery System Shows Overall Response Rate Of 60.5% In Eye Cancer That Spreads To Liver
Delcath Systems Inc's (NASDAQ: DCTH) single-institution retrospective study data on CHEMOSAT Hepatic Delivery System for liver dominant metastatic uveal melanoma (mUM)  
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.